The post Stablecoins Could Become the Backbone of AI Commerce appeared on BitcoinEthereumNews.com. At the World Economic Forum in Davos, Allaire said billions ofThe post Stablecoins Could Become the Backbone of AI Commerce appeared on BitcoinEthereumNews.com. At the World Economic Forum in Davos, Allaire said billions of

Stablecoins Could Become the Backbone of AI Commerce

At the World Economic Forum in Davos, Allaire said billions of AI agents may soon transact continuously on behalf of users and businesses, requiring fast, programmable, and globally accessible money. He and Changpeng Zhao both see crypto as the natural financial layer for AI activity, a view that already influences product development as companies like Coinbase and Google.

Stablecoins May Power the AI Economy

Jeremy Allaire, the chief executive of stablecoin issuer Circle, believes the global economy is on the cusp of a major structural shift driven by artificial intelligence and digital money. At the World Economic Forum in Davos, Allaire said that within the next three to five years, billions of autonomous AI agents could be operating continuously across the global economy, executing transactions and performing tasks without direct human involvement. 

According to Allaire, these agents will require a financial system that matches their speed, programmability, and global reach, and he argues that stablecoins are currently the only viable solution capable of meeting those demands at scale.

Allaire described a future in which AI agents conduct economic activity on behalf of users, businesses, and institutions, handling payments, subscriptions, and microtransactions around the clock. He explained that traditional banking rails and card-based systems are poorly suited to this environment due to friction, geographic limitations, and reliance on human authorization. On the other hand, stablecoins offer near-instant settlement, internet-native design, and the ability to integrate directly into automated software systems.

Changpeng Zhao, co-founder of Binance, argued that crypto assets are likely to become the default currency for AI-driven commerce, and predicted that autonomous agents will use blockchain-based payments for everyday transactions like booking travel, purchasing services, or settling restaurant bills. He dismissed the idea that AI agents would rely on credit cards or legacy payment methods, and described blockchain as the most natural technological interface for machine-driven economic activity.

This vision is already beginning to influence product development across both crypto and traditional technology sectors. In May, Coinbase’s development team introduced an online payments protocol known as x402, which is designed specifically to allow AI agents to transact using stablecoins over the internet. The system revives the long-unused HTTP 402 “Payment Required” status code and combines it with Ethereum Improvement Proposal 3009, enabling pre-signed payment authorizations. This approach allows automated transfers to occur without repeated manual approvals or the need for agents to manage gas fees directly.

At the same time, large technology companies are positioning themselves to play a role in agentic commerce. On Jan. 11, Google unveiled its Universal Commerce Protocol, to support payments executed by AI agents on behalf of users. Google’s system relies on its Agent Payment Protocol 2, with Google Pay acting as the default handler for US dollar transactions.

Source: https://coinpaper.com/13974/stablecoins-could-become-the-backbone-of-ai-commerce

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26